Paul Daruwala, Chief Operating Officer at Cidara Therapeutics, Inc. (CDTX), sold 16,199 shares at $0.68 ($11K) on 2022-09-12, disclosed to the SEC on 2022-09-13.
Open-market sale of $11k CDTX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CDTX | SELL | 2020-06-25 | $3K | — | Filing → |
| CDTX | SELL | 2020-01-06 | $8K | — | Filing → |
| CDTX | SELL | 2019-10-03 | $6K | — | Filing → |